Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Adamas Pharma (NQ: ADMS )

5.090 USD UNCHANGED
Streaming Delayed Price Updated: 5:13 PM EDT, Apr 16, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 5.090
Bid (Size) 2.450 (1)
Ask (Size) 5.220 (1)
Prev. Close 5.090
Today's Range 5.090 - 5.090
52wk Range 2.430 - 9.150
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Adamas Announces Two Presentations for the American Academy of Neurology 73rd Annual Meeting
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced... 
From Business Wire News Releases
Adamas to Present at Upcoming Needham Conference
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced... 
From Business Wire News Releases

Performance

YTD
+13.62%
+13.62%
1 Month
-9.59%
-9.59%
3 Month
+12.61%
+12.61%
6 Month
+19.20%
+19.20%
1 Year
+45.01%
+45.01%

More News

Read More
Adamas publishes new data analyses demonstrating GOCOVRI treatment more than doubled ON time without dyskinesia in patients with Parkinson’s disease
From Business Wire News Releases
Adamas Announces New Employment Inducement Grant
From Business Wire News Releases
Adamas Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
From Business Wire News Releases
Adamas Pharmaceuticals Announces Pricing of Follow-on Public Offering
From Business Wire News Releases
Adamas Pharmaceuticals Announces Launch of Follow-on Public Offering
From Business Wire News Releases
Adamas' Gocovri Treatment Doubles ON Time Without Dyskinesia In Parkinson's disease, New Analysis Shows
Tags News Health Care Benzinga
From Benzinga
Adamas Reports Fourth Quarter and Full Year 2020 Financial Results
From Business Wire News Releases
First Week of May 21st Options Trading For Adamas Pharmaceuticals (ADMS)
Tags Stocks
From Market News Video
Adamas to Present at Upcoming Healthcare Conferences
From Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.